Vertero
Business Services · 11-50 Employees
View Company Info for Free
Overview
Website
www.vertero.comRevenue
<$5 MillionIndustry
About Vertero
Vertero Therapeutics is pioneering science beyond the brain to treat neurodegenerative diseases at their source. Verteros development pipeline of differentiated therapies targets the peripheral nervous system to delay onset and slow progression of challenging conditions such as Parkinsons disease. The company's lead program, VT-5006, is designed to precisely treat a validated target in the gut that feeds the protein aggregation and inflammation implicated in Parkinsons disease. Vertero is preparing to initiate a Phase 1 clinical trial of VT-5006. The company also has an asset targeting bile acid dysregulation in early development for undisclosed indications.Explore more
SIC Code 87,873NAICS Code 54,541Show more
Vertero Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vertero
Sign Up For FreeTo access detailed company insights
Vertero Therapeutics is pioneering science beyond the brain to treat neurodegenerative diseases at their source. Verteros development pipeline of differentiated therapies targets the peripheral nervous system to delay onset and slow progression of challenging conditions such as Parkinsons disease. The company's lead program, VT-5006, is designed to... Read More
